Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Selective Laser Photocoagulation Of Communicating Vessels

Research Leaders

10 sponsors active, led by Advancing a Healthier Wisconsin Endowment

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed3
Not Yet Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Selective Laser Photocoagulation Of Communicating Vessels2
  • Substudy Only Maternalinfant Pharmacogenomic Assessment Postnatally1
  • Doppler Ultrasound Of Fetal Renal Artery1
  • Verasonics Vantage 256 Ultrasound1
  • Fetal Magnetocardiogram And Neonatal Electrocardiogram1

Active Sponsors

  • Advancing a Healthier Wisconsin Endowment1
  • Virginia Polytechnic Institute and State University1
  • University of Southern California1
  • Carilion Clinic1
  • University of Wisconsin, Madison1

Top Investigators

Related Conditions

  • Monochorionic Twins1
  • Pregnancy1
  • Sudden Infant Death1
  • Ultrasound1
  • Pregnancy Loss1

Activity Timeline